The Unique U.S.-Russian Relationship in Biological Science and Biotechnology Recent Experience and Future Directions (2013) / Chapter Skim
Currently Skimming:
Appendix F.3: Russia's Pharmaceutical and Biotechnology Sectors
Appendix F.3: Russia's Pharmaceutical and Biotechnology Sectors
Pages 229-232
The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.
From page 229... ...
However, funding began only in 2010. Given the uncertainties in moving forward, the timetable is widely recognized as being overly optimistic; and some anticipated outcomes may not materialize, even after delays.
|
From page 230... ...
INTERESTS OF RUSSIAN BIOTECHNOLOGY SOCIETY AND BIOINDUSTRY ASSOCIATION A Regional Biotechnology Programs: Tatarstan Republic, Chuvash Republic, Kirov Oblast, Penza Oblast, Karelia Republic, Tomsk Oblast, Novosibirsk Oblast, Kaliningrad Oblast, Belgorod Oblast, Voronezh Oblast.
|
From page 231... ...
Poplyxen for biobetters aimed at diabetes mellitus, Alzheimer disease, chronic kidney disease, and cardiovascular disorders. • BIND Biosciences, with an investment by Rusnano of $25 million, is to develop new therapeutics against cancer, inflammatory diseases, and cardiovascular disorders.
|
From page 232... ...
Updated during subsequent discussions in Moscow.
|
Key Terms
This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More
information on Chapter Skim is available.